{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:42:51Z","timestamp":1791520971612,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Disruption of the epithelium in the female reproductive tract (FRT) is hypothesized to increase HIV infection risk by interfering with barrier protection and facilitating HIV-target cell recruitment. Here we determined whether Tenofovir (TFV), used vaginally in HIV prevention trials, and Tenofovir alafenamide (TAF), an improved prodrug of TFV, interfere with wound healing in the human FRT. TFV treatment of primary epithelial cells and fibroblasts from the endometrium (EM), endocervix (CX) and ectocervix (ECX) significantly delayed wound closure. Reestablishment of tight junctions was compromised in EM and CX epithelial cells even after wound closure occurred. In contrast, TAF had no inhibitory effect on wound closure or tight junction formation following injury. TAF accumulated inside genital epithelial cells as TFV-DP, the active drug form. At elevated levels of TAF treatment to match TFV intracellular TFV-DP concentrations, both equally impaired barrier function, while wound closure was more sensitive to TFV. Furthermore, TFV but not TAF increased elafin and MIP3a secretion following injury, molecules known to be chemotactic for HIV-target cells. Our results highlight the need of evaluating antiretroviral effects on genital wound healing in future clinical trials. A possible link between delayed wound healing and increased risk of HIV acquisition deserves further investigation.<\/jats:p>","DOI":"10.1038\/srep45725","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T11:41:11Z","timestamp":1491219671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tenofovir Inhibits Wound Healing of Epithelial Cells and Fibroblasts from the Upper and Lower Human Female Reproductive Tract"],"prefix":"10.1038","volume":"7","author":[{"given":"Marta","family":"Rodriguez-Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickey V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Bodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Rossoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Wira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"BFsrep45725_CR1","unstructured":"WHO. Global summary of the AIDS epidemic, http:\/\/www.who.int\/hiv\/data\/epi_core_2016.png?ua=1 (2015)."},{"key":"BFsrep45725_CR2","unstructured":"UNAIDS. Global AIDS update, http:\/\/www.unaids.org\/en\/resources\/documents\/2016\/Global-AIDS-update-2016 (2016)."},{"key":"BFsrep45725_CR3","unstructured":"U.S. Department of Justice. National Crime Victimization Survey. 2009\u20132013., (U.S. Department of Justice, 2014)."},{"key":"BFsrep45725_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jemermed.2008.08.024","volume":"39","author":"T Zink","year":"2010","unstructured":"Zink, T. et al. Comparison of methods for identifying ano-genital injury after consensual intercourse. The Journal of emergency medicine 39, 113\u2013118, doi: 10.1016\/j.jemermed.2008.08.024 (2010).","journal-title":"The Journal of emergency medicine"},{"key":"BFsrep45725_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/QAI.0000000000000824","volume":"71","author":"BM Brawner","year":"2016","unstructured":"Brawner, B. M. et al. Exploring Genitoanal Injury and HIV Risk Among Women: Menstrual Phase, Hormonal Birth Control, and Injury Frequency and Prevalence. J Acquir Immune Defic Syndr 71, 207\u2013212, doi: 10.1097\/QAI.0000000000000824 (2016).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BFsrep45725_CR6","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Intimate partner violence and HIV infection among women: a systematic review and meta-analysis. Vol. 17 (2014).","DOI":"10.7448\/IAS.17.1.18845"},{"key":"BFsrep45725_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/aji.12029","volume":"69","author":"KK Venkatesh","year":"2013","unstructured":"Venkatesh, K. K. & Cu-Uvin, S. Assessing the relationship between cervical ectopy and HIV susceptibility: implications for HIV prevention in women. Am J Reprod Immunol 69 Suppl 1, 68\u201373, doi: 10.1111\/aji.12029 (2013).","journal-title":"Am J Reprod Immunol"},{"key":"BFsrep45725_CR8","unstructured":"Organization, W. H. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV (2015)."},{"key":"BFsrep45725_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten, J. M. et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England journal of medicine 367, 399\u2013410, doi: 10.1056\/NEJMoa1108524 (2012).","journal-title":"The New England journal of medicine"},{"key":"BFsrep45725_CR10","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant, R. M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England journal of medicine 363, 2587\u20132599, doi: 10.1056\/NEJMoa1011205 (2010).","journal-title":"The New England journal of medicine"},{"key":"BFsrep45725_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen, M. C. et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. The New England journal of medicine 367, 423\u2013434, doi: 10.1056\/NEJMoa1110711 (2012).","journal-title":"The New England journal of medicine"},{"key":"BFsrep45725_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo, J. M. et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. The New England journal of medicine 372, 509\u2013518, doi: 10.1056\/NEJMoa1402269 (2015).","journal-title":"The New England journal of medicine"},{"key":"BFsrep45725_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme, L. et al. Preexposure prophylaxis for HIV infection among African women. The New England journal of medicine 367, 411\u2013422, doi: 10.1056\/NEJMoa1202614 (2012).","journal-title":"The New England journal of medicine"},{"key":"BFsrep45725_CR14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"Q Abdool Karim","year":"2010","unstructured":"Abdool Karim, Q. et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329, 1168\u20131174, doi: 10.1126\/science.1193748 (2010).","journal-title":"Science"},{"key":"BFsrep45725_CR15","doi-asserted-by":"publisher","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","volume":"26","author":"A van der Straten","year":"2012","unstructured":"van der Straten, A., Van Damme, L., Haberer, J. E. & Bangsberg, D. R. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 26, F13\u201319, doi: 10.1097\/QAD.0b013e3283522272 (2012).","journal-title":"AIDS"},{"key":"BFsrep45725_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.04.015","volume":"119","author":"E De Clercq","year":"2016","unstructured":"De Clercq, E. Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF). Biochemical pharmacology 119, 1\u20137, doi: 10.1016\/j.bcp.2016.04.015 (2016).","journal-title":"Biochemical pharmacology"},{"key":"BFsrep45725_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3851\/IMP2767","volume":"19","author":"RA Bam","year":"2014","unstructured":"Bam, R. A., Birkus, G., Babusis, D., Cihlar, T. & Yant, S. R. Metabolism and antiretroviral activity of tenofovir alafenamide in CD4+ T-cells and macrophages from demographically diverse donors. Antiviral therapy 19, 669\u2013677, doi: 10.3851\/IMP2767 (2014).","journal-title":"Antiviral therapy"},{"key":"BFsrep45725_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.antiviral.2016.05.012","volume":"132","author":"NA Margot","year":"2016","unstructured":"Margot, N. A., Liu, Y., Miller, M. D. & Callebaut, C. High resistance barrier to tenofovir alafenamide is driven by higher loading of tenofovir diphosphate into target cells compared to tenofovir disoproxil fumarate. Antiviral research 132, 50\u201358, doi: 10.1016\/j.antiviral.2016.05.012 (2016).","journal-title":"Antiviral research"},{"key":"BFsrep45725_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1473-3099(15)00412-0","volume":"16","author":"S Dhanireddy","year":"2016","unstructured":"Dhanireddy, S. & Baeten, J. M. Tenofovir alafenamide for HIV: time to switch? The Lancet. Infectious diseases 16, 3\u20135, doi: 10.1016\/S1473-3099(15)00412-0 (2016).","journal-title":"The Lancet. Infectious diseases"},{"key":"BFsrep45725_CR20","doi-asserted-by":"publisher","first-page":"e100863","DOI":"10.1371\/journal.pone.0100863","volume":"9","author":"Z Shen","year":"2014","unstructured":"Shen, Z. et al. Sex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture. PloS one 9, e100863, doi: 10.1371\/journal.pone.0100863 (2014).","journal-title":"PloS one"},{"key":"BFsrep45725_CR21","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1128\/AAC.03270-14","volume":"58","author":"N Biswas","year":"2014","unstructured":"Biswas, N. et al. Effects of tenofovir on cytokines and nucleotidases in HIV-1 target cells and the mucosal tissue environment in the female reproductive tract. Antimicrobial agents and chemotherapy 58, 6444\u20136453, doi: 10.1128\/AAC.03270-14 (2014).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"BFsrep45725_CR22","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.fertnstert.2008.10.047","volume":"92","author":"KD Coleman","year":"2009","unstructured":"Coleman, K. D., Wright, J. A., Ghosh, M., Wira, C. R. & Fahey, J. V. Estradiol modulation of hepatocyte growth factor by stromal fibroblasts in the female reproductive tract. Fertil Steril 92, 1107\u20131109, doi: 10.1016\/j.fertnstert.2008.10.047 (2009).","journal-title":"Fertil Steril"},{"key":"BFsrep45725_CR23","doi-asserted-by":"crossref","unstructured":"Patterson, K. B. et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Science translational medicine 3, 112re114, doi: 10.1126\/scitranslmed.3003174 (2011).","DOI":"10.1126\/scitranslmed.3003174"},{"key":"BFsrep45725_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jim.2013.09.001","volume":"397","author":"AW Boesch","year":"2013","unstructured":"Boesch, A. W. et al. A multiplexed assay to detect antimicrobial peptides in biological fluids and cell secretions. Journal of immunological methods 397, 71\u201376, doi: 10.1016\/j.jim.2013.09.001 (2013).","journal-title":"Journal of immunological methods"},{"key":"BFsrep45725_CR25","doi-asserted-by":"crossref","unstructured":"Rodriguez-Garcia, M. et al. Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV. Mucosal immunology, doi: 10.1038\/mi.2016.72 (2016).","DOI":"10.1016\/j.jri.2016.04.167"},{"key":"BFsrep45725_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/QAI.0000000000000607","volume":"69","author":"AD Kashuba","year":"2015","unstructured":"Kashuba, A. D. et al. Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness. J Acquir Immune Defic Syndr 69, 264\u2013269, doi: 10.1097\/QAI.0000000000000607 (2015).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BFsrep45725_CR27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/jac\/dkt532","volume":"69","author":"M Markowitz","year":"2014","unstructured":"Markowitz, M. et al. Phase I\/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults. The Journal of antimicrobial chemotherapy 69, 1362\u20131369, doi: 10.1093\/jac\/dkt532 (2014).","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"BFsrep45725_CR28","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/mi.2015.63","volume":"8","author":"G Leoni","year":"2015","unstructured":"Leoni, G., Neumann, P. A., Sumagin, R., Denning, T. L. & Nusrat, A. Wound repair: role of immune-epithelial interactions. Mucosal immunology 8, 959\u2013968, doi: 10.1038\/mi.2015.63 (2015).","journal-title":"Mucosal immunology"},{"key":"BFsrep45725_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2567.2009.03165.x","volume":"129","author":"M Ghosh","year":"2010","unstructured":"Ghosh, M. et al. Trappin-2\/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 129, 207\u2013219, doi: 10.1111\/j.1365-2567.2009.03165.x (2010).","journal-title":"Immunology"},{"key":"BFsrep45725_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1600-0897.2009.00713.x","volume":"62","author":"M Ghosh","year":"2009","unstructured":"Ghosh, M. et al. CCL20\/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol 62, 60\u201371 (2009).","journal-title":"Am J Reprod Immunol"},{"key":"BFsrep45725_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1046\/j.1365-2567.2004.01898.x","volume":"112","author":"TM Schaefer","year":"2004","unstructured":"Schaefer, T. M., Desouza, K., Fahey, J. V., Beagley, K. W. & Wira, C. R. Toll-like receptor (TLR) expression and TLR-mediated cytokine\/chemokine production by human uterine epithelial cells. Immunology 112, 428\u2013436, doi: 10.1046\/j.1365-2567.2004.01898.x (2004).","journal-title":"Immunology"},{"key":"BFsrep45725_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nri3819","volume":"15","author":"CR Wira","year":"2015","unstructured":"Wira, C. R., Rodriguez-Garcia, M. & Patel, M. V. The role of sex hormones in immune protection of the female reproductive tract. Nature reviews. Immunology 15, 217\u2013230, doi: 10.1038\/nri3819 (2015).","journal-title":"Nature reviews. Immunology"},{"key":"BFsrep45725_CR33","doi-asserted-by":"publisher","first-page":"e1000852","DOI":"10.1371\/journal.ppat.1000852","volume":"6","author":"A Nazli","year":"2010","unstructured":"Nazli, A. et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS pathogens 6, e1000852, doi: 10.1371\/journal.ppat.1000852 (2010).","journal-title":"PLoS pathogens"},{"key":"BFsrep45725_CR34","doi-asserted-by":"publisher","first-page":"e1004440","DOI":"10.1371\/journal.ppat.1004440","volume":"10","author":"DJ Stieh","year":"2014","unstructured":"Stieh, D. J. et al. Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tract. PLoS pathogens 10, e1004440, doi: 10.1371\/journal.ppat.1004440 (2014).","journal-title":"PLoS pathogens"},{"key":"BFsrep45725_CR35","doi-asserted-by":"publisher","first-page":"e0129769","DOI":"10.1371\/journal.pone.0129769","volume":"10","author":"K Smith-McCune","year":"2015","unstructured":"Smith-McCune, K. et al. Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study. PloS one 10, e0129769, doi: 10.1371\/journal.pone.0129769 (2015).","journal-title":"PloS one"},{"key":"BFsrep45725_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/154407370601900109","volume":"19","author":"A Weinberg","year":"2006","unstructured":"Weinberg, A., Quinones-Mateu, M. E. & Lederman, M. M. Role of human beta-defensins in HIV infection. Advances in dental research 19, 42\u201348 (2006).","journal-title":"Advances in dental research"},{"key":"BFsrep45725_CR37","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1172\/JCI2015","volume":"101","author":"LB Margolis","year":"1998","unstructured":"Margolis, L. B., Glushakova, S., Grivel, J. C. & Murphy, P. M. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. The Journal of clinical investigation 101, 1876\u20131880, doi: 10.1172\/JCI2015 (1998).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep45725_CR38","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1042\/BST0391427","volume":"39","author":"AG Drannik","year":"2011","unstructured":"Drannik, A. G., Henrick, B. M. & Rosenthal, K. L. War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection. Biochemical Society transactions 39, 1427\u20131432, doi: 10.1042\/BST0391427 (2011).","journal-title":"Biochemical Society transactions"},{"key":"BFsrep45725_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","volume":"17","author":"JJ Oppenheim","year":"2005","unstructured":"Oppenheim, J. J. & Yang, D. Alarmins: chemotactic activators of immune responses. Current opinion in immunology 17, 359\u2013365, doi: 10.1016\/j.coi.2005.06.002 (2005).","journal-title":"Current opinion in immunology"},{"key":"BFsrep45725_CR40","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/mi.2014.26","volume":"7","author":"M Rodriguez-Garcia","year":"2014","unstructured":"Rodriguez-Garcia, M., Barr, F. D., Crist, S. G., Fahey, J. V. & Wira, C. R. Phenotype and susceptibility to HIV infection of CD4 Th17 cells in the human female reproductive tract. Mucosal immunology 7, 1375\u20131385, doi: 10.1038\/mi.2014.26 (2014).","journal-title":"Mucosal immunology"},{"key":"BFsrep45725_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/mi.2015.28","volume":"9","author":"VR Joag","year":"2016","unstructured":"Joag, V. R. et al. Identification of preferential CD4+ T-cell targets for HIV infection in the cervix. Mucosal immunology 9, 1\u201312, doi: 10.1038\/mi.2015.28 (2016).","journal-title":"Mucosal immunology"},{"key":"BFsrep45725_CR42","doi-asserted-by":"crossref","unstructured":"Hladik, F. et al. Mucosal effects of tenofovir 1% gel. eLife 4, doi: 10.7554\/eLife.04525 (2015).","DOI":"10.7554\/eLife.04525"},{"key":"BFsrep45725_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/QAI.0b013e3182965d45","volume":"63","author":"PJ Ruane","year":"2013","unstructured":"Ruane, P. J. et al. Antiviral activity, safety, and pharmacokinetics\/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults. J Acquir Immune Defic Syndr 63, 449\u2013455, doi: 10.1097\/QAI.0b013e3182965d45 (2013).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BFsrep45725_CR44","doi-asserted-by":"publisher","first-page":"e78814","DOI":"10.1371\/journal.pone.0078814","volume":"8","author":"N Biswas","year":"2013","unstructured":"Biswas, N. et al. Effect of tenofovir on nucleotidases and cytokines in HIV-1 target cells. PloS one 8, e78814, doi: 10.1371\/journal.pone.0078814 (2013).","journal-title":"PloS one"},{"key":"BFsrep45725_CR45","doi-asserted-by":"crossref","unstructured":"De Clercq, E. Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF). Biochemical pharmacology, doi: 10.1016\/j.bcp.2016.04.015 (2016).","DOI":"10.1016\/j.bcp.2016.04.015"},{"key":"BFsrep45725_CR46","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/infdis\/jiw312","volume":"214","author":"I Massud","year":"2016","unstructured":"Massud, I. et al. Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian\/Human Immunodeficiency Virus Infection. The Journal of infectious diseases 214, 1058\u20131062, doi: 10.1093\/infdis\/jiw312 (2016).","journal-title":"The Journal of infectious diseases"},{"key":"BFsrep45725_CR47","unstructured":"Garrett, K. L. C. M. L., Prince, H. M., Sykes, C., Schauer, A., Peery, A., Rooney, J., McCallister, S., Gay, C. & Kashuba, A. In Conference on Retroviruses and Opportunistic Infections (CROI)(Boston, 2016)."},{"key":"BFsrep45725_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-cellbio-092910-154251","volume":"27","author":"KJ Sonnemann","year":"2011","unstructured":"Sonnemann, K. J. & Bement, W. M. Wound repair: toward understanding and integration of single-cell and multicellular wound responses. Annual review of cell and developmental biology 27, 237\u2013263, doi: 10.1146\/annurev-cellbio-092910-154251 (2011).","journal-title":"Annual review of cell and developmental biology"},{"key":"BFsrep45725_CR49","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature07039","volume":"453","author":"GC Gurtner","year":"2008","unstructured":"Gurtner, G. C., Werner, S., Barrandon, Y. & Longaker, M. T. Wound repair and regeneration. Nature 453, 314\u2013321, doi: 10.1038\/nature07039 (2008).","journal-title":"Nature"},{"key":"BFsrep45725_CR50","doi-asserted-by":"crossref","unstructured":"Romas, L. et al. Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression. AIDS research and human retroviruses, doi: 10.1089\/AID.2015.0381 (2016).","DOI":"10.1089\/aid.2015.0381"},{"key":"BFsrep45725_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/phn.12216","volume":"33","author":"BM Brawner","year":"2016","unstructured":"Brawner, B. M., Alexander, K. A., Fannin, E. F., Baker, J. L. & Davis, Z. M. The Role of Sexual Health Professionals in Developing a Shared Concept of Risky Sexual Behavior as it Relates to HIV Transmission. Public Health Nurs 33, 139\u2013150, doi: 10.1111\/phn.12216 (2016).","journal-title":"Public Health Nurs"},{"key":"BFsrep45725_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/aji.12027","volume":"69","author":"M Ghosh","year":"2013","unstructured":"Ghosh, M., Rodriguez-Garcia, M. & Wira, C. R. Immunobiology of genital tract trauma: endocrine regulation of HIV acquisition in women following sexual assault or genital tract mutilation. Am J Reprod Immunol 69 Suppl 1, 51\u201360, doi: 10.1111\/aji.12027 (2013).","journal-title":"Am J Reprod Immunol"},{"key":"BFsrep45725_CR53","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1542\/peds.2006-0230","volume":"120","author":"J McCann","year":"2007","unstructured":"McCann, J., Miyamoto, S., Boyle, C. & Rogers, K. Healing of nonhymenal genital injuries in prepubertal and adolescent girls: a descriptive study. Pediatrics 120, 1000\u20131011, doi: 10.1542\/peds.2006-0230 (2007).","journal-title":"Pediatrics"},{"key":"BFsrep45725_CR54","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/01.aids.0000210608.70762.c3","volume":"20","author":"KH Mayer","year":"2006","unstructured":"Mayer, K. H. et al. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS 20, 543\u2013551, doi: 10.1097\/01.aids.0000210608.70762.c3 (2006).","journal-title":"AIDS"},{"key":"BFsrep45725_CR55","doi-asserted-by":"crossref","unstructured":"Roberts, S. T. et al. Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: A prospective cohort study. J Acquir Immune Defic Syndr, doi: 10.1097\/QAI.0000000000001093 (2016).","DOI":"10.1097\/QAI.0000000000001093"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep45725.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep45725","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/srep45725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/srep45725.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T23:17:24Z","timestamp":1671837444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep45725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,2]]}},"alternative-id":["BFsrep45725"],"URL":"https:\/\/doi.org\/10.1038\/srep45725","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]},"assertion":[{"value":"14 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45725"}}